Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability
- PMID: 21829380
- PMCID: PMC3145627
- DOI: 10.1371/journal.pgen.1002198
Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability
Abstract
Complex trait genome-wide association studies (GWAS) provide an efficient strategy for evaluating large numbers of common variants in large numbers of individuals and for identifying trait-associated variants. Nevertheless, GWAS often leave much of the trait heritability unexplained. We hypothesized that some of this unexplained heritability might be due to common and rare variants that reside in GWAS identified loci but lack appropriate proxies in modern genotyping arrays. To assess this hypothesis, we re-examined 7 genes (APOE, APOC1, APOC2, SORT1, LDLR, APOB, and PCSK9) in 5 loci associated with low-density lipoprotein cholesterol (LDL-C) in multiple GWAS. For each gene, we first catalogued genetic variation by re-sequencing 256 Sardinian individuals with extreme LDL-C values. Next, we genotyped variants identified by us and by the 1000 Genomes Project (totaling 3,277 SNPs) in 5,524 volunteers. We found that in one locus (PCSK9) the GWAS signal could be explained by a previously described low-frequency variant and that in three loci (PCSK9, APOE, and LDLR) there were additional variants independently associated with LDL-C, including a novel and rare LDLR variant that seems specific to Sardinians. Overall, this more detailed assessment of SNP variation in these loci increased estimates of the heritability of LDL-C accounted for by these genes from 3.1% to 6.5%. All association signals and the heritability estimates were successfully confirmed in a sample of ∼10,000 Finnish and Norwegian individuals. Our results thus suggest that focusing on variants accessible via GWAS can lead to clear underestimates of the trait heritability explained by a set of loci. Further, our results suggest that, as prelude to large-scale sequencing efforts, targeted re-sequencing efforts paired with large-scale genotyping will increase estimates of complex trait heritability explained by known loci.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- R56 DK062370/DK/NIDDK NIH HHS/United States
- U01 HL084729/HL/NHLBI NIH HHS/United States
- R01 HG000376/HG/NHGRI NIH HHS/United States
- HG002651/HG/NHGRI NIH HHS/United States
- R56 HG000376/HG/NHGRI NIH HHS/United States
- R01 DK062370/DK/NIDDK NIH HHS/United States
- HL084729/HL/NHLBI NIH HHS/United States
- 263-MA-410953/PHS HHS/United States
- ImNIH/Intramural NIH HHS/United States
- U01 DK062370/DK/NIDDK NIH HHS/United States
- DK062370/DK/NIDDK NIH HHS/United States
- HG005581/HG/NHGRI NIH HHS/United States
- RC2 HG005581/HG/NHGRI NIH HHS/United States
- N01-AG-1-2109/AG/NIA NIH HHS/United States
- R01 HG002651/HG/NHGRI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
